|
1
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding Z, Jiang L, Zhang K and Huang R:
Short- and long-term outcomes of conversion in laparoscopic
gastrectomy for gastric cancer. J BUON. 23:1004–1012.
2018.PubMed/NCBI
|
|
3
|
Xu C, Cui H, Li H, Wu Y, An H and Guo C:
Long non-coding RNA ZEB2-AS1 expression is associated with disease
progression and predicts outcome in gastric cancer patients. J
BUON. 24:663–671. 2019.PubMed/NCBI
|
|
4
|
de Boer WB, Ee H and Kumarasinghe MP:
Neoplastic lesions of gastric adenocarcinoma and poximal polyposis
syndrome (GAPPS) are gastric phenotype. Am J Surg Pathol. 42:1–8.
2018.PubMed/NCBI
|
|
5
|
Markowski AR, Markowska A and
Guzinska-Ustymowicz K: Pathophysiological and clinical aspects of
gastric hyperplastic polyps. World J Gastroenterol. 22:8883–8891.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nomura E and Okajima K:
Function-preserving gastrectomy for gastric cancer in Japan. World
J Gastroenterol. 22:5888–5895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akimoto T, Muto S, Kutsuwada T, Kutsuwada
K and Nagata D: Peritoneal dialysis and malignancy: An experience
with a patient complicated by gastric carcinoma. Clin Med Insights
Case Rep. 12:11795476198351762019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Çolak Ş, Gürbulak B, Çakar E and Bektaş H:
Resection of mucosal and submucosal gastrointestinal lesions and a
double endoscope experience. JSLS. 23:e2018.00096. 2019. View Article : Google Scholar
|
|
9
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Botti G, Marra L, Malzone MG, Anniciello
A, Botti C, Franco R and Cantile M: LncRNA HOTAIR as prognostic
circulating marker and potential therapeutic target in patients
with tumor diseases. Curr Drug Targets. 18:27–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Guo G, Zhong Z, Sun L, Liao L, Wang
X, Cao Q and Chen H: Long non-coding RNA FLVCR1-AS1 sponges miR-155
to promote the tumorigenesis of gastric cancer by targeting c-Myc.
Am J Transl Res. 11:793–805. 2019.PubMed/NCBI
|
|
13
|
Li J, Xu Q, Wang W and Sun S: MIR100HG: A
credible prognostic biomarker and an oncogenic lncRNA in gastric
cancer. Biosci Rep. 39:BSR201901712019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marín-Béjar O, Mas AM, González J,
Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E,
Guo S, et al: The human lncRNA LINC-PINT inhibits tumor cell
invasion through a highly conserved sequence element. Genome Biol.
18:2022017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamagishi M and Uchimaru K: Targeting EZH2
in cancer therapy. Curr Opin Oncol. 29:375–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan KS, Lin CY, Liao TW, Peng CM, Lee SC,
Liu YJ, Chan WP and Chou RH: EZH2 in cancer progression and
potential application in cancer therapy: A Friend or Foe? Int J Mol
Sci. 18:11722017. View Article : Google Scholar
|
|
17
|
Wassef M, Luscan A, Aflaki S, Zielinski D,
Jansen PW, Baymaz HI, Battistella A, Kersouani C, Servant N,
Wallace MR, et al: EZH1/2 function mostly within canonical PRC2 and
exhibit proliferation-dependent redundancy that shapes mutational
signatures in cancer. Proc Natl Acad Sci USA. 116:6075–6080. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun C, Ban Y, Wang K, Sun Y and Zhao Z:
SOX5 promotes breast cancer proliferation and invasion by
transactivation of EZH2. Oncol Lett. 17:2754–2762. 2019.PubMed/NCBI
|
|
19
|
Labbé DP, Sweeney CJ, Brown M, Galbo P,
Rosario S, Wadosky KM, Ku SY, Sjöström M, Alshalalfa M, Erho N, et
al: TOP2A and EZH2 provide early detection of an aggressive
prostate cancer subgroup. Clin Cancer Res. 23:7072–7083. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Emran AA, Chatterjee A, Rodger EJ, Tiffen
JC, Gallagher SJ, Eccles MR and Hersey P: Targeting DNA methylation
and EZH2 activity to overcome melanoma resistance to immunotherapy.
Trends Immunol. 40:328–344. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramakrishnan S, Granger V, Rak M, Hu Q,
Attwood K, Aquila L, Krishnan N, Osiecki R, Azabdaftari G, Guru K,
et al: Inhibition of EZH2 induces NK cell-mediated differentiation
and death in muscle-invasive bladder cancer. Cell Death Differ.
26:2100–2114. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu L, Despotovic N, Kovacs MS, Pin CL and
Luyt LG: 18F-labeled PET probe targeting enhancer of Zeste
homologue 2 (EZH2) for cancer imaging. ACS Med Chem Lett.
10:334–340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Liu ZM and Xu BH: A meta-analysis of
the effect of microRNA-34a on the progression and prognosis of
gastric cancer. Eur Rev Med Pharmacol Sci. 22:8281–8287.
2018.PubMed/NCBI
|
|
24
|
Lin Y, Zhang CS, Li SJ, Li Z and Sun FB:
LncRNA LOC554202 promotes proliferation and migration of gastric
cancer cells through regulating p21 and E-cadherin. Eur Rev Med
Pharmacol Sci. 22:8690–8697. 2018.PubMed/NCBI
|
|
25
|
Hernanz N, Rodríguez de Santiago E, Marcos
Prieto HM, Jorge Turrión MÁ, Barreiro Alonso E, Rodríguez Escaja C,
Jiménez Jurado A, Sierra M, Pérez Valle I, Volpato N, et al:
Characteristics and consequences of missed gastric cancer: A
multicentric cohort study. Dig Liver Dis. 51:894–900. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen C, Tang X, Liu Y, Zhu J and Liu J:
Induction/reversal of drug resistance in gastric cancer by
non-coding RNAs (Review). Int J Oncol. 54:1511–1524.
2019.PubMed/NCBI
|
|
27
|
Yamagata Y, Saito K, Ban S, Fujii A and
Oya M: The origin of p40-negative and CDX2-positive primary
squamous cell carcinoma of the stomach: Case report. World J Surg
Oncol. 17:532019.PubMed/NCBI
|
|
28
|
Jain VS, Kawale D, Jain SM, Waghmare C and
Pemmaraju G: Various addiction patterns, dietary habits, associated
medical problems, and socioeconomic status in gastrointestinal
malignancies: A prospective study in rural area of Maharashtra,
India. J Cancer Res Ther. 15:104–107. 2019.PubMed/NCBI
|
|
29
|
Jarroux J, Morillon A and Pinskaya M:
History, discovery, and classification of lncRNAs. Adv Exp Med
Biol. 1008:1–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andersen RE and Lim DA: Forging our
understanding of lncRNAs in the brain. Cell Tissue Res. 371:55–71.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Léveillé N and Baglio SR:
Exosome-transferred lncRNAs at the core of cancer bone lesions.
Crit Rev Oncol Hematol. 139:125–127. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mao Z, Wu Y, Zhou J and Xing C:
Salinomycin reduces epithelial-mesenchymal transition-mediated
multidrug resistance by modifying long noncoding RNA HOTTIP
expression in gastric cancer cells. Anticancer Drugs. 30:892–899.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qin H, Xu J, Gong L, Jiang B and Zhao W:
The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell
carcinoma by stabilizing CARM1. Biochem Biophys Res Commun.
512:34–40. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang M, Hou J, Wang Y, Xie M, Wei C, Nie
F, Wang Z and Sun M: Long noncoding RNA LINC00673 is activated by
SP1 and exerts oncogenic properties by interacting with LSD1 and
EZH2 in gastric cancer. Mol Ther. 25:1014–1026. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang Y, Zhu F, Wang Q, Ding Y, Ying R and
Zeng L: Inhibition of EZH2 and EGFR produces a synergistic effect
on cell apoptosis by increasing autophagy in gastric cancer cells.
Onco Targets Ther. 11:8455–8463. 2018. View Article : Google Scholar : PubMed/NCBI
|
